Taxonomy of segmental myocardial systolic dysfunction

Adam K McDiarmid1, Pierpaolo Pellicori2, John G Cleland2

  • 1Multidisciplinary Cardiovascular Research Centre & Division of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, UK.

Insights

Nomenclature for myocardial health and disease is imprecise, hindering clinical application. This review proposes a taxonomy of myocardial dysfunction using non-invasive imaging for clearer definitions in ischemic heart disease and cardiomyopathy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pathophysiology

Background:

  • Inconsistent terminology for myocardial health and disease complicates clinical practice.
  • Terms like 'viable' and 'hibernating' are often misused for chronic contractile dysfunction in ischemic heart disease.
  • Variability in imaging modalities further challenges consistent definitions of myocardial states.

Purpose of the Study:

  • To address the lack of precise definitions in myocardial health and disease nomenclature.
  • To describe diverse myocardial pathologies in ischemic heart disease and cardiomyopathy.
  • To establish a taxonomy of myocardial dysfunction based on non-invasive imaging assessment.

Main Methods:

  • Review of current literature on myocardial pathologies and nomenclature.
  • Analysis of non-invasive imaging techniques used to assess myocardial function.
  • Synthesis of information to propose a classification system for myocardial dysfunction.

Main Results:

  • Identified imprecision and interchangeability of terms like 'viable' and 'hibernating' myocardium.
  • Highlighted challenges posed by different imaging modalities in defining myocardial states.
  • Recognized the need for standardized definitions to improve clinical interpretation of trial outcomes.

Conclusions:

  • A clear taxonomy of myocardial dysfunction is needed for accurate clinical application.
  • Standardized definitions and assessment using non-invasive imaging are crucial for understanding ischemic heart disease and cardiomyopathy.
  • Improved nomenclature will enhance the interpretation and utility of clinical trial results.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
640
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
746
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
727
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
759
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K